GB1498261A - Influenza vaccines - Google Patents

Influenza vaccines

Info

Publication number
GB1498261A
GB1498261A GB1290/75A GB129075A GB1498261A GB 1498261 A GB1498261 A GB 1498261A GB 1290/75 A GB1290/75 A GB 1290/75A GB 129075 A GB129075 A GB 129075A GB 1498261 A GB1498261 A GB 1498261A
Authority
GB
United Kingdom
Prior art keywords
influenza
components
virus
type
cationic detergent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1290/75A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of GB1498261A publication Critical patent/GB1498261A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Detergent Compositions (AREA)
  • Enzymes And Modification Thereof (AREA)
GB1290/75A 1974-01-14 1975-01-13 Influenza vaccines Expired GB1498261A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH44774A CH589453A5 (enrdf_load_html_response) 1974-01-14 1974-01-14

Publications (1)

Publication Number Publication Date
GB1498261A true GB1498261A (en) 1978-01-18

Family

ID=4187233

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1290/75A Expired GB1498261A (en) 1974-01-14 1975-01-13 Influenza vaccines

Country Status (27)

Country Link
JP (2) JPS58407B2 (enrdf_load_html_response)
AT (1) AT345449B (enrdf_load_html_response)
AU (1) AU500250B2 (enrdf_load_html_response)
BE (1) BE824372A (enrdf_load_html_response)
CA (1) CA1049406A (enrdf_load_html_response)
CH (1) CH589453A5 (enrdf_load_html_response)
CS (1) CS191254B2 (enrdf_load_html_response)
DD (1) DD116239A5 (enrdf_load_html_response)
DE (1) DE2500785B2 (enrdf_load_html_response)
DK (1) DK140003B (enrdf_load_html_response)
ES (1) ES433759A1 (enrdf_load_html_response)
FI (1) FI54053C (enrdf_load_html_response)
FR (1) FR2257305B1 (enrdf_load_html_response)
GB (1) GB1498261A (enrdf_load_html_response)
HK (1) HK56380A (enrdf_load_html_response)
HU (1) HU173920B (enrdf_load_html_response)
IE (1) IE40794B1 (enrdf_load_html_response)
IL (1) IL46426A (enrdf_load_html_response)
MY (1) MY8100204A (enrdf_load_html_response)
NL (1) NL166622C (enrdf_load_html_response)
NO (1) NO143128C (enrdf_load_html_response)
PH (1) PH14458A (enrdf_load_html_response)
PL (1) PL93689B1 (enrdf_load_html_response)
SE (1) SE427238B (enrdf_load_html_response)
SU (1) SU616997A3 (enrdf_load_html_response)
YU (1) YU41289B (enrdf_load_html_response)
ZA (1) ZA75259B (enrdf_load_html_response)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6793928B1 (en) 1997-11-25 2004-09-21 Duphar International Research Bv Vaccines with an LTB adjuvant
WO2009029695A1 (en) * 2007-08-28 2009-03-05 Baxter International Inc. Method for producing viral vaccines
WO2015071177A1 (en) 2013-11-15 2015-05-21 Novartis Ag Removal of residual cell culture impurities

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2829089A1 (de) * 1977-07-13 1979-02-01 Sandoz Ag Subunit-vakzine
JPH0688911B2 (ja) * 1985-06-06 1994-11-09 国立予防衛生研究所長 インフルエンザワクチン及びその製造方法
TW570803B (en) * 1997-04-09 2004-01-11 Duphar Int Res Influenza vaccine
DE19938767C2 (de) * 1999-08-16 2002-10-24 Tad Pharma Gmbh Spaltimpfstoffe
CA2627971A1 (en) * 2005-11-01 2007-05-10 Novartis Vaccines And Diagnostics Gmbh & Co Kg. Cell-derived viral vaccines with low levels of residual cell dna by beta-propiolactone treatment

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6793928B1 (en) 1997-11-25 2004-09-21 Duphar International Research Bv Vaccines with an LTB adjuvant
WO2009029695A1 (en) * 2007-08-28 2009-03-05 Baxter International Inc. Method for producing viral vaccines
US8497112B2 (en) 2007-08-28 2013-07-30 Baxter International Inc. Method for producing viral vaccines
RU2496519C2 (ru) * 2007-08-28 2013-10-27 Бакстер Интернэшнл Инк. Способ получения препарата, содержащего вирусные антигены, и применение препарата
AU2008293513B2 (en) * 2007-08-28 2013-11-21 Nanotherapeutics, Inc. Method for producing viral vaccines
WO2015071177A1 (en) 2013-11-15 2015-05-21 Novartis Ag Removal of residual cell culture impurities

Also Published As

Publication number Publication date
AT345449B (de) 1978-09-11
CA1049406A (en) 1979-02-27
NO750031L (enrdf_load_html_response) 1975-08-11
NL166622C (nl) 1981-09-15
SU616997A3 (ru) 1978-07-25
DE2500785A1 (de) 1975-07-31
PH14458A (en) 1981-07-29
IE40794L (en) 1975-07-14
YU5875A (en) 1984-04-30
DK1475A (enrdf_load_html_response) 1975-09-01
NL7500301A (nl) 1975-07-16
HU173920B (hu) 1979-09-28
CS191254B2 (en) 1979-06-29
NL166622B (nl) 1981-04-15
YU41289B (en) 1987-02-28
PL93689B1 (enrdf_load_html_response) 1977-06-30
JPS56127319A (en) 1981-10-06
HK56380A (en) 1980-10-16
FR2257305A1 (enrdf_load_html_response) 1975-08-08
DK140003C (enrdf_load_html_response) 1979-10-29
CH589453A5 (enrdf_load_html_response) 1977-07-15
JPS58407B2 (ja) 1983-01-06
DE2500785B2 (de) 1980-01-03
IL46426A0 (en) 1975-04-25
FR2257305B1 (enrdf_load_html_response) 1982-03-19
FI750014A7 (enrdf_load_html_response) 1975-07-15
DE2500785C3 (enrdf_load_html_response) 1980-09-11
SE7500130L (enrdf_load_html_response) 1975-07-15
JPS6035326B2 (ja) 1985-08-14
FI54053C (fi) 1978-10-10
JPS50100224A (enrdf_load_html_response) 1975-08-08
ATA21475A (de) 1978-01-15
ZA75259B (en) 1976-08-25
DD116239A5 (enrdf_load_html_response) 1975-11-12
MY8100204A (en) 1981-12-31
AU500250B2 (en) 1979-05-17
BE824372A (fr) 1975-07-14
SE427238B (sv) 1983-03-21
AU7730575A (en) 1976-07-15
NO143128C (no) 1980-12-29
FI54053B (fi) 1978-06-30
NO143128B (no) 1980-09-15
IE40794B1 (en) 1979-08-15
DK140003B (da) 1979-06-05
ES433759A1 (es) 1977-02-16
IL46426A (en) 1978-01-31

Similar Documents

Publication Publication Date Title
Schierman et al. Adjuvant activity of erythrocyte isoantigens
Cella et al. Maturation, activation, and protection of dendritic cells induced by double-stranded RNA
HU9401056D0 (en) Porcine reproductive respiratory syndrome vaccine and diagnostic
ES422961A1 (es) Procedimiento para preparar una suspension de virus.
BR9106374A (pt) Vacina oral e processo de extrair uma imunoresponsta em um mamifero
GB1498261A (en) Influenza vaccines
US3674864A (en) Process for stabilizing preparations of interfering viruses
Kurrle et al. Influenza virus‐specific T cell‐mediated cytotoxicity: integration of the virus antigen into the target cell membrane is essential for target cell formation
ES379641A1 (es) Procedimiento de produccion de antigenos inactivos para preparados farmaceuticos.
ES8104405A1 (es) Procedimiento para preparar una vacuna de virus de gripe
ES430415A1 (es) Un procedimiento para preparar una vacuna de virus de la gripe atenuado.
GB2001326A (en) Glycoproteins from paramyxovirus and vaccines therefrom
Mims Rift Valley fever virus in mice. II. Adsorption and multiplication of virus
IE40221B1 (en) Influenza vaccines
GB1256457A (en) Diethylaminoethyldextran (deae-d) as adjuvant for vaccines for active immunisation
AU5573196A (en) A pluripotent vaccine against enveloped viruses
GB1140316A (en) Influenza virus sub-unit vaccine
US3132073A (en) Measles vaccine
GB1327870A (en) Process for the manufacture of a vaccine against infectious bursitis of chickens
GB1434181A (en) Vaccine for the prevention and treatment of vascular conditions
GB777018A (en) Poliomyelitis vaccine products and methods for preparing the same
郭元吉 et al. Influenza C virus isolated from pigs in China
PT100460A (pt) Partiiculas derivadas de virus de herpes e vacinas que as contem
EP0374817A3 (en) Method for disrupting virus particles
AR120296A1 (es) Vacuna de partículas de virus de tipo chikungunya y sus métodos de uso

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
732 Registration of transactions, instruments or events in the register (sect. 32/1977)
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19940113